Is a food supplement a medicine in Nigeria, Ghana, Kenya and South Africa? Which regulator, which class, and what a blister changes

We checked all of these on 14 October 2026. This article reports what the regulators published. It is not legal advice, and your importer or a regulatory adviser confirms how your own product is classified. For the Saudi side of the same question, see food supplement or medicine in Saudi Arabia; for the general answer on blisters, see does a blister make a supplement a medicine.

Does a blister pack make a supplement a medicine in these four countries?

No, in the texts we read. We searched the NAFDAC guideline for imported herbal remedies and dietary supplements, the FDA Ghana supplement guideline, the PPB health supplements guideline of June 2025, and SAHPRA's Roadmap and Health Supplements documents, and the word blister is in none of them. What each text turns on is what is claimed, what is in the product and at what level, and who the regulator is.

That is a statement about the five texts, not about every rule in four countries. A text we did not read could say otherwise, and we found no public case where a regulator reclassified a supplement because of its pack. The same blister, with the same tablet, is judged on the same grounds as a bottle.

The packaging does appear in the files, for other reasons. Ghana asks for stability data in the pack the product is sold in. Kenya asks for a description of primary and secondary packaging in the dossier and for approval of pack or label changes made before sale. Those are documentation points, not classification points.

Nigeria: is it a supplement or a medicine for NAFDAC?

NAFDAC's guideline covers "Herbal Remedies/Dietary Supplements" as one group, and states that none may be manufactured, imported, exported, advertised, sold or distributed in Nigeria unless registered. The guideline we read is R&R-GDL-007-00, in force from 1 June 2018 with a review date of 31 May 2023. We read a copy hosted by a third party, not the version on nafdac.gov.ng, so check the current text with NAFDAC.

For an imported product the guideline lists a declaration notarised in Nigeria, a power of attorney from the manufacturer or a contract manufacturing agreement, a certificate of manufacture and free sale authenticated by the Nigerian embassy or high commission, a Certificate of Analysis on the laboratory's letterhead, evidence of the importer's incorporation in Nigeria, trademark registration, the label or artwork, a letter inviting a GMP inspection of the factory, and coloured artwork with a leaflet insert. It also asks for evidence of accepted use and that the product is registered in the country of origin.

The five steps are documentation, an import permit after which labels are vetted, laboratory samples, an approval meeting and a notification of registration. The guideline gives 120 working days from acceptance of the submission to the registration number, and says the clock stops once compliance queries are issued; an application whose queries go unanswered for 90 working days is closed. Advertising needs its own permit after registration.

The guideline does not draw a line between supplement and medicine in the text we read. NAFDAC's published actions show where it acts, and they are set out below.

Ghana: what does the FDA call a supplement?

FDA Ghana defines supplements as concentrated sources of nutrients or other substances produced "in a pharmaceutical dosage form such as tablets, gelatine capsules (soft or hard), sachets, syrups and powders". A tablet, a capsule or a sachet is therefore inside the supplement definition, not a mark of a medicine.

The limits are in what the product contains and what it is for. The definition covers vitamins and minerals "with concentration less than the recommended daily allowance", and allows the listed ingredients "on the condition that their sole function is supplementation and improvement of body function". "Medicinal Purpose" is defined separately, as use for treating or preventing a disease, diagnosing or ascertaining the presence and extent of a physiological function, contraception, inducing anaesthesia, or altering normal physiologic function in any way in humans; the text we read does not say what follows from it. The applicant is the product owner or the licence holder, contract manufacturing is shown on the label and insert, and stability is tested for zone IVb in the pack in which the product is sold. The guideline is FDA/HMD/GL-FS/2012/01, issue 1 March 2013, so it is old; ask FDA Ghana whether a newer one applies.

Kenya: why does the Pharmacy and Poisons Board register supplements, and what does KEBS do?

The PPB is Kenya's medicines regulator, and its guideline of June 2025 sets out the registration of "health supplements". That makes it the supplement regulator without making the supplement a prescription medicine. The guideline describes a supplement as a tablet, capsule, powder, softgel, gel capsule, granules or liquid taken by mouth and "not represented for use as a conventional food".

Claims "to prevent, diagnose, treat, cure or mitigate any disease" are barred. A product should also contain no drug substance listed in the Schedules of the Pharmacy and Poisons Act and no substance of known pharmacological activity, and its daily intake of each nutrient should not be above 200 % of the recommended daily allowance or above the upper tolerable level. The applicant is the patent holder, the manufacturer or a Local Technical Representative, a Kenyan company with full responsibility. Registration is typically valid for five years with annual retention. The label carries batch, manufacture and expiry dates in English or Kiswahili, and the guideline says applicants should include a scientific package insert in the pack.

The guideline also says each consignment is inspected at the port of entry by PPB inspectors and only registered supplements are accepted. KEBS is a separate matter: destination inspection of shipments, described in our article on pre-arrival filings from a contractor's news report, not from KEBS itself. We found no PPB warning or recall about a supplement for 2025 or 2026.

South Africa: are health supplements medicines?

In the law, yes, in a narrow sense: SAHPRA treats "health supplements" as a sub-category of Category D complementary medicines under the Medicines and Related Substances Act 101 of 1965. That is a regulatory category, not a prescription one. Health supplements "allow only LOW RISK indications and substances", and indications that refer to treating or curing specific diseases are "not suitable".

Registration is by a phased call-up under section 14, and importers and wholesalers of any Category D product need a SAHPRA licence under section 22C(1)(b). The call-up dates in SAHPRA's schedule are a timetable for categories, not a review time, so no review period can be quoted. We read the SAHPRA documents in archived copies, as the live site refused our connection.

One gap matters here. SAHPRA has a Guideline for Borderline Products, SAHPGL-CRO-01 v1, which would say when a product is food and when it is a medicine. We could not open it. Until someone reads it, we do not state where that line falls.

What do the four have in common?

Three things: a drug-regulator route, a claims bar, and a dose or ingredient test. In all four the pack is silent.

• The regulator reaches supplements. NAFDAC, the PPB and SAHPRA are the same bodies that handle medicines. A supplement file there is not a prescription-medicine file.
• Claims are the first test. Kenya bars disease claims outright, South Africa calls them unsuitable, Ghana defines a medicinal purpose, and NAFDAC acts on products sold as supplements that behave as drugs.
• Dose and ingredients are the second. Ghana limits vitamins and minerals to below the recommended daily allowance; Kenya asks for no nutrient above 200 % of it and no substance of known pharmacological activity; South Africa allows only low-risk substances.
• A local party is in the file. Nigeria asks for evidence of the importer's incorporation there, Kenya for a Local Technical Representative, South Africa for a licensed importer; in Ghana the applicant is the product owner or licence holder and the text we read names no local entity. Whether the factory itself may apply is for your importer to confirm; we do not apply.

What do regulators actually act on?

Hidden drug substances and disease claims, in the cases we found. We found no case in which a pack was the reason for reclassification.

The third row is the only one in our sample where a supplement's pack is named. It is a safety recall about child-resistant closure for a product containing iron, and says nothing of blister versus bottle.

These cases are a guide to what a brand checks before printing, not a route round registration. The legitimate checks are on the product: no undeclared active substance, no disease statement on the carton, foil or website, and doses within the limit of the country of sale. A third-party accredited laboratory can test for prohibited substances, and we arrange that on request, with the report in your brand's name.

What does your situation decide?

Each line shows what the choice costs in time, in channel or in risk.

What do we supply for each file, and what do we not do?

Our work is manufacturing and packing: food supplements for your brand, with tablets and capsules sealed in blisters and cartoned for your market. Registering and classifying products are not ours, and we do not apply to NAFDAC, FDA Ghana, the PPB or SAHPRA; the importer or brand owner takes that step.

What we supply is the documents a file can draw on: a Certificate of Analysis and a specification with each batch, and copies of the plant's certificates with their numbers on request. The plant is ISO 22000, GMP and HACCP certified and registered with the US FDA as a food facility; the GMP is for food supplements, not pharmaceutical GMP. Where a country asks for legalisation, we arrange it. Details are on our pages for Africa, West Africa, East Africa and export documents.

Questions buyers ask about supplements and medicines in these four countries

Read more

Does a blister make a supplement a medicine · Saudi Arabia: supplement or medicine · Pre-arrival filings: Egypt, Nigeria, Kenya · Africa · West Africa · East Africa · Export documents